NCT06661759

Brief Summary

Sleep problems are more common and more severe in children with epilepsy. The purpose of this study is to develop and evaluate the effect of a clinic-based and technology-supported sleep intervention for improving sleep and health in children with epilepsy and their parents.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
17mo left

Started Nov 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress55%
Nov 2024Dec 2027

First Submitted

Initial submission to the registry

October 24, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 28, 2024

Completed
22 days until next milestone

Study Start

First participant enrolled

November 19, 2024

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

July 8, 2026

Status Verified

November 1, 2025

Enrollment Period

3.1 years

First QC Date

October 24, 2024

Last Update Submit

July 6, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sleep Efficiency by Actigraphy

    Actigraphy is an objective sleep measurement method that assesses physical motion through a small device worn on the non-dominant wrist. Children's sleep will be objectively assessed for 7 days using actigraphy at each assessment time point. Sleep efficiency, a key indicator of sleep quality, is calculated as total nighttime sleep divided by time in bed × 100%.

    At baseline and at 3, 6, and 12 months after randomization.

Secondary Outcomes (8)

  • Sleep Onset Latency

    At baseline and at 3, 6, and 12 months after randomization.

  • Wake After Sleep Onset (WASO)

    At baseline and at 3, 6, and 12 months after randomization.

  • Total Nighttime Sleep

    At baseline and at 3, 6, and 12 months after randomization.

  • Daily 24-hour Sleep Duration

    At baseline and at 3, 6, and 12 months after randomization.

  • Children's Sleep Habits Questionnaire (CSHQ)

    At baseline and at 3, 6, and 12 months after randomization.

  • +3 more secondary outcomes

Study Arms (2)

Experimental intervention group

EXPERIMENTAL

standard pediatric neurology care plus a hybrid in-person and digital sleep education program

Behavioral: Clinic-based and technology-supported sleep intervention

Usual care group

NO INTERVENTION

standard pediatric neurology care

Interventions

CATS sleep intervention: The in-person sleep education and consultation will consist of 3 face-to-face, one-on-one sessions held 3 months apart during the child's routine clinic visit.The digital component of the sleep intervention will extend in-person education by providing ongoing support. Participants will receive one digital session per week for four weeks after the baseline, 3-month, and 6-month clinic visits, totaling 12 sessions.

Experimental intervention group

Eligibility Criteria

Age18 Months - 9 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children aged between 1.5 and 9 years with a confirmed diagnosis of epilepsy.
  • Parents with sufficient Chinese language skills to fully comprehend the trial and complete questionnaires.

You may not qualify if:

  • Children who are bedridden.
  • Children with a documented sleep disorder, such as obstructive or central sleep apnea and sleep-related movement disorders
  • Children with severe motor dysfunction that prevents accurate sleep-wake differentiation via actigraphy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, Taiwan

RECRUITING

MeSH Terms

Conditions

Epilepsy

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Shao-Yu Tsai

    National Taiwan University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 24, 2024

First Posted

October 28, 2024

Study Start

November 19, 2024

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

July 8, 2026

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations